Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Earnings Calendar - Aug 7, 2023
Showing earnings announcements on Aug 07, 2023
Name | Company | Market Cap | EPS (Forecast) | EPS (Actual) | Revenue (Forecast) | Revenue (Actual) | Time | Analyst Consensus | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
 | Palantir Technologies | $60.53B | $0.05 | $533.38M | xxxxxxxxxxxxx | |||||
 | Lucid Group | $7.80B | -$0.34 | $181.58M | xxxxxxxxxxxxx | |||||
 | Crispr Therapeutics AG | $4.92B | -$2.13 | $1.80M | xxxxxxxxxxxxx | |||||
 | Beyond Meat | $405.53M | -$0.84 | $108.74M | xxxxxxxxxxxxx | |||||
 | Skyworks Solutions | $18.64B | $1.67 | $1.07B | xxxxxxxxxxxxx | |||||
 | BioNTech SE | $20.43B | -$0.90 | $682.03M | xxxxxxxxxxxxx | |||||
 | Paramount Global Class B | $7.91B | $0.00 | $7.44B | xxxxxxxxxxxxx | |||||
 | Viatris | $14.38B | $0.71 | $3.86B | xxxxxxxxxxxxx | |||||
 | Oneok | $47.87B | $1.02 | $4.67B | xxxxxxxxxxxxx | |||||
 | Chegg | $358.78M | $0.29 | $176.49M | xxxxxxxxxxxxx | |||||
 | Tyson Foods | $21.29B | $0.26 | $13.63B | xxxxxxxxxxxxx | |||||
 | RingCentral | $3.22B | $0.75 | $536.19M | xxxxxxxxxxxxx | |||||
 | Cara Therapeutics | $20.36M | -$0.54 | $6.50M | xxxxxxxxxxxxx | |||||
 | T2 Biosystems | $88.54M | -$26.67 | $2.17M | xxxxxxxxxxxxx | |||||
 | Tellurian | $823.54M | -$0.05 | $52.75M | xxxxxxxxxxxxx | |||||
 | Aquestive Therapeutics | $347.77M | -$0.12 | $11.01M | xxxxxxxxxxxxx | |||||
 | Hims & Hers Health | $4.68B | -$0.05 | $204.95M | xxxxxxxxxxxxx | |||||
 | Axsome Therapeutics | $4.11B | -$1.21 | $40.88M | xxxxxxxxxxxxx | |||||
 | Coterra Energy | $19.19B | $0.34 | $1.26B | xxxxxxxxxxxxx | |||||
 | KKR & Co | $105.17B | $0.71 | $1.17B | xxxxxxxxxxxxx | |||||
 | MannKind | $1.59B | -$0.04 | $42.95M | xxxxxxxxxxxxx | |||||
 | Five9 | $3.45B | $0.39 | $214.67M | xxxxxxxxxxxxx | |||||
 | Arcturus Therapeutics | $648.25M | -$0.24 | $49.33M | xxxxxxxxxxxxx | |||||
 | Arrowhead Pharmaceuticals | $3.50B | -$0.57 | $45.42M | xxxxxxxxxxxxx | |||||
 | Turtle Beach | $337.91M | -$0.34 | $50.43M | xxxxxxxxxxxxx | |||||
 | Ellington Financial | $1.10B | $0.45 | $50.17M | xxxxxxxxxxxxx | |||||
 | Ocular Therapeutix | $1.31B | -$0.30 | $14.62M | xxxxxxxxxxxxx | |||||
 | Medifast | $224.10M | $1.44 | $270.20M | xxxxxxxxxxxxx | |||||
 | Microvast Holdings | $134.08M | -$0.11 | $64.35M | xxxxxxxxxxxxx | |||||
 | Alto Ingredients | $119.54M | -$0.05 | $298.25M | xxxxxxxxxxxxx | |||||
 | Kosmos Energy | $2.57B | $0.10 | $310.56M | xxxxxxxxxxxxx | |||||
 | FS KKR Capital | $5.67B | $0.76 | $449.80M | xxxxxxxxxxxxx | |||||
 | Capital Southwest | $1.19B | $0.64 | $38.74M | xxxxxxxxxxxxx | |||||
 | Itau Unibanco | $54.90B | $0.18 | $7.99B | xxxxxxxxxxxxx | |||||
 | Astria Therapeutics | $655.11M | -$0.47 | $0.00 | xxxxxxxxxxxxx | |||||
 | Sabra Healthcare REIT | $3.84B | $0.09 | $158.72M | xxxxxxxxxxxxx | |||||
 | Sequans Communications S A | $32.43M | -$0.11 | $9.80M | xxxxxxxxxxxxx | |||||
 | Asure | $264.07M | <$0.01 | $25.49M | xxxxxxxxxxxxx | |||||
 | Compugen | $158.47M | -$0.12 | $0.00 | xxxxxxxxxxxxx | |||||
 | FibroGen | $115.39M | -$0.70 | $34.73M | xxxxxxxxxxxxx | |||||
 | Ready Capital | $1.57B | $0.37 | $160.12M | xxxxxxxxxxxxx | |||||
 | SAGE Therapeutics | $661.40M | -$2.55 | $2.94M | xxxxxxxxxxxxx | |||||
 | Annexon Biosciences | $657.78M | -$0.54 | $0.00 | xxxxxxxxxxxxx | |||||
 | CoreCivic | $1.63B | $0.12 | $467.46M | xxxxxxxxxxxxx | |||||
 | Gladstone Land | $536.86M | -$0.13 | $21.50M | xxxxxxxxxxxxx | |||||
 | EverQuote | $919.53M | -$0.32 | $71.57M | xxxxxxxxxxxxx | |||||
 | Hawaiian Electric | $1.86B | $0.53 | $845.37M | xxxxxxxxxxxxx | |||||
 | Genius Sports Limited | $1.55B | -$0.05 | $80.58M | xxxxxxxxxxxxx | |||||
 | Protalix | $85.05M | -$0.04 | $10.20M | xxxxxxxxxxxxx | |||||
 | Essential Utilities | $11.14B | $0.34 | $469.07M | xxxxxxxxxxxxx | |||||
 | Danaos | $1.62B | $6.92 | $227.38M | xxxxxxxxxxxxx | |||||
 | Aecom Technology | $12.28B | $0.94 | $1.67B | xxxxxxxxxxxxx | |||||
 | Capricor Therapeutics | $139.75M | -$0.35 | $3.00M | xxxxxxxxxxxxx | |||||
 | Kyndryl Holdings Incorporation | $6.21B | -$1.11 | $4.09B | xxxxxxxxxxxxx | |||||
 | International Flavors & Fragrances | $25.24B | $1.10 | $3.07B | xxxxxxxxxxxxx | |||||
 | Gogo | $1.19B | $0.14 | $103.24M | xxxxxxxxxxxxx | |||||
 | Golub Capital Bdc | $4.07B | $0.42 | $149.79M | xxxxxxxxxxxxx | |||||
 | Zai Lab | $1.87B | -$0.79 | $70.48M | xxxxxxxxxxxxx | |||||
 | Celanese | $15.19B | $2.48 | $2.96B | xxxxxxxxxxxxx | |||||
 | Aclaris Therapeutics | $99.06M | -$0.45 | $1.90M | xxxxxxxxxxxxx | |||||
 | National Cinemedia | $551.43M | -$0.70 | $67.90M | ― | xxxxxxxxxxxxx | ||||
 | American States Water | $3.08B | $0.78 | $128.00M | xxxxxxxxxxxxx | |||||
 | Teradata | $3.11B | $0.45 | $445.09M | xxxxxxxxxxxxx | |||||
 | Adeia | $1.25B | $0.25 | $89.01M | xxxxxxxxxxxxx | |||||
 | Sterling Construction | $3.56B | $0.93 | $495.00M | xxxxxxxxxxxxx | |||||
 | Freshpet | $5.71B | -$0.41 | $184.71M | xxxxxxxxxxxxx | |||||
 | SkyWater Technology | $357.02M | -$0.13 | $63.88M | xxxxxxxxxxxxx | |||||
 | AG Mortgage | $228.13M | $0.11 | $13.74M | xxxxxxxxxxxxx | |||||
 | Service Properties | $961.41M | -$0.02 | $499.65M | xxxxxxxxxxxxx | |||||
 | Apartment Investment & Management | $1.31B | ― | ― | xxxxxxxxxxxxx | |||||
 | Prime Medicine, Inc. | $673.37M | -$0.42 | $0.00 | xxxxxxxxxxxxx | |||||
 | Veeco | $2.23B | $0.30 | $157.89M | xxxxxxxxxxxxx | |||||
 | DocGo | $379.86M | $0.03 | $119.77M | xxxxxxxxxxxxx | |||||
 | Quantum-Si | $157.42M | -$0.17 | $400.00K | xxxxxxxxxxxxx | |||||
 | ReShape Lifesciences | $5.92M | -$1.79 | $2.61M | xxxxxxxxxxxxx | |||||
 | MagnaChip | $189.43M | -$0.23 | $60.50M | xxxxxxxxxxxxx | |||||
 | Krystal Biotech | $6.10B | -$1.26 | $0.00 | ― | xxxxxxxxxxxxx | ||||
 | Arcus Biosciences | $1.44B | -$1.10 | $31.81M | xxxxxxxxxxxxx | |||||
 | Passage Bio | $56.52M | -$0.47 | $0.00 | xxxxxxxxxxxxx | |||||
 | Transportadora De Gas Sa Ord B | $3.73B | $0.01 | ― | xxxxxxxxxxxxx | |||||
 | Compass | $2.20B | -$0.06 | $1.51B | xxxxxxxxxxxxx | |||||
 | Henry Schein | $9.26B | $1.28 | $3.13B | xxxxxxxxxxxxx | |||||
 | Enlivex | $28.39M | -$0.43 | ― | ― | xxxxxxxxxxxxx | ||||
 | AxoGen | $403.83M | -$0.12 | $39.08M | xxxxxxxxxxxxx | |||||
 | Tidewater | $5.19B | $0.67 | $218.84M | xxxxxxxxxxxxx | |||||
 | Delek Logistics | $1.95B | $0.83 | $281.25M | xxxxxxxxxxxxx | |||||
 | Delek US Holdings | $1.53B | $0.73 | $3.26B | xxxxxxxxxxxxx | |||||
 | Inogen | $227.99M | -$0.59 | $92.16M | xxxxxxxxxxxxx | |||||
 | Maravai Lifesciences Holdings | $2.31B | $0.01 | $71.09M | xxxxxxxxxxxxx | |||||
 | AnaptysBio | $1.01B | -$1.70 | $2.68M | xxxxxxxxxxxxx | |||||
 | AEye Inc | $12.17M | -$2.70 | $600.00K | xxxxxxxxxxxxx | |||||
 | Elanco Animal Health | $6.37B | $0.05 | $1.04B | xxxxxxxxxxxxx | |||||
 | Stoke Therapeutics | $826.63M | -$0.64 | $3.44M | xxxxxxxxxxxxx | |||||
 | National Storage Affiliates | $5.02B | $0.22 | $212.58M | xxxxxxxxxxxxx | |||||
 | Theravance Biopharma | $498.49M | -$0.21 | $15.29M | xxxxxxxxxxxxx | |||||
 | Sohu | $490.44M | ― | ― | xxxxxxxxxxxxx | |||||
 | Clarus | $234.00M | -$0.02 | $91.97M | xxxxxxxxxxxxx | |||||
 | Crane NXT | $3.65B | $0.91 | $336.52M | xxxxxxxxxxxxx | |||||
 | Tactile Systems Technology | $301.30M | -$0.05 | $65.28M | xxxxxxxxxxxxx | |||||
 | Inmune Bio | $169.73M | -$0.40 | $38.00K | xxxxxxxxxxxxx |
Rows:
Earnings News
FAQ
When is Earnings Season?
The earnings season usually begins one to two weeks after the end of the last month of each quarter (December, March, June, and September).
How do earnings affect stock prices?
A company's earnings report reveals its profitability and financial stability. If a company’s earnings are reported above expectations, its stock price tends to rise. However, depending on forward guidance and macroeconomic factors, a stock price is still susceptible to volatility.
Is it better to buy a stock before or after earnings?
Stock prices tend to be more volatile before and after a company reports its earnings. Investors should develop an investment thesis using Earnings Reports Insights and other datasets before making any investment decisions.